3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Elevated renalase levels in patients with acute coronary microvascular dysfunction – A possible biomarker for ischemia

      Read this article at

      ScienceOpenPublisher
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <div class="section"> <a class="named-anchor" id="S1"> <!-- named anchor --> </a> <h5 class="section-title" id="d6201391e214">Aims</h5> <p id="P1">We explored the relationship between inflammation, renalase an anti-inflammatory protein, and acute chest pain with coronary microvascular dysfunction (CMD). </p> </div><div class="section"> <a class="named-anchor" id="S2"> <!-- named anchor --> </a> <h5 class="section-title" id="d6201391e219">Methods and Results</h5> <p id="P2">We used cardiac Rb-82 PET/CT imaging to diagnose coronary artery disease (CAD/CALC) (defect or coronary calcification) and CMD (depressed coronary flow reserve without CAD) in patients with chest pain in an emergency department (ED). Blood samples were collected pre-imaging within 24 hours of ED presentation and were analyzed for renalase and inflammatory markers including C-reactive protein, interleukins, interferon gamma, tumor necrosis factor, vascular endothelial growth factor, and metalloproteinases. Exclusions were age ≤30 years, myocardial infarction, hemodynamic instability, hypertensive crisis, heart failure or dialysis. </p> <p id="P3">Between 6/2014-11/2015, 80 patients undergoing PET/CT provided blood and were categorized as normal (18%), CAD/CALC (27%) and CMD (55%). Median renalase values were highest in patients with CMD (5503 ng/ml; IQR 3070) compared to patients with normal flows (4266 ng/ml; IQR 1503; p = 0.02) or CAD/CALC (4069 ng/ml IQR 1850; p =0.004). CMD patients had similar median values for inflammatory markers as normal patients (p &gt; 0.05). Renalase remained an independent predictor of CMD (OR 1.34; 95% CI= 1.1-1.7, per 1,000 ng/ml) after adjustment for smoking, family history, obesity and Framingham risk score. In a model for CMD diagnosis with Framingham risk score, typical angina history and CRP, renalase improved discrimination from C-statistic=0.60 (95% CI 0.47, 0.73) to 0.70 (95% CI, 0.59-0.82). </p> </div><div class="section"> <a class="named-anchor" id="S3"> <!-- named anchor --> </a> <h5 class="section-title" id="d6201391e226">Conclusion</h5> <p id="P4">We found elevated renalase in response to ischemia from acute CMD. Its role as a biomarker needs validation in larger trials. </p> </div>

          Related collections

          Author and article information

          Journal
          International Journal of Cardiology
          International Journal of Cardiology
          Elsevier BV
          01675273
          January 2019
          January 2019
          Article
          10.1016/j.ijcard.2018.12.061
          2c1b8018-2fd4-4e31-ac62-f44efcc8d6e6
          © 2019

          https://www.elsevier.com/tdm/userlicense/1.0/

          History

          Comments

          Comment on this article